US Patent 8686025 Therapeutic lactams
Patent 8686025 was granted and assigned to Allergan, Inc. on April, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Dec, 2023
Golden AI
Edits made to:
Article (+64 characters)
Article
Patent abstract
Disclosed herein is a compound having a structure
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David W. Old0
Robert M. Burk0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08686025 Therapeutic lactams US Patent 8686025 Therapeutic lactams
Infobox
Patent Number
086860250
Patent Number
86860250
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086860250
Date of Patent
April 1, 2014
0Patent Application Number
123347040
Date Filed
December 15, 2008
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08686025 Therapeutic lactams
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08686025
Date of patent
April 1, 2014
Patent application number
12334704
Date Filed
December 15, 2008
Patent primary examiner
Find more entities like US Patent 8686025 Therapeutic lactams
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
